LEBWOHL, M. G.; MEHTA, N. N.; GOTTLIEB, A. B.; MENDELSOHN, A. M. Tildrakizumab Efficacy by Metabolic Syndrome Status in Psoriasis: Post Hoc Analysis of 3-Year Data from the Phase 3 Resurface 1 And Resurface 2 Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 5, p. s42, 2020. DOI: 10.25251/skin.4.supp.42. Disponível em: https://www.jofskin.org/index.php/skin/article/view/991. Acesso em: 5 jul. 2022.